Korean Medication Algorithm for Depressive Disorders 2017: Third Revision.

about

Korean Medication Algorithm for Depressive Disorders 2017: Third Revision.

Item

http://www.wikidata.org/entity/Q48514039

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Korean Medication Algorithm for Depressive Disorders 2017: Third Revision.

@en

Korean Medication Algorithm for Depressive Disorders 2017: Third Revision.

@nl

type

Item

label

Korean Medication Algorithm for Depressive Disorders 2017: Third Revision.

@en

Korean Medication Algorithm for Depressive Disorders 2017: Third Revision.

@nl

prefLabel

Korean Medication Algorithm for Depressive Disorders 2017: Third Revision.

@en

Korean Medication Algorithm for Depressive Disorders 2017: Third Revision.

@nl

P1476

Korean Medication Algorithm for Depressive Disorders 2017: Third Revision

@en

P2093

Duk-In Jon

http://www.w3.org/2001/XMLSchema#string

Hee Ryung Wang

http://www.w3.org/2001/XMLSchema#string

Jeong Seok Seo

http://www.w3.org/2001/XMLSchema#string

Jung Goo Lee

http://www.w3.org/2001/XMLSchema#string

Kyung Joon Min

http://www.w3.org/2001/XMLSchema#string

Se-Hoon Shim

http://www.w3.org/2001/XMLSchema#string

Won Kim

http://www.w3.org/2001/XMLSchema#string

Won-Myong Bahk

http://www.w3.org/2001/XMLSchema#string

Young Sup Woo

http://www.w3.org/2001/XMLSchema#string

Young-Min Park

http://www.w3.org/2001/XMLSchema#string

P2860

Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes

Newer generation antidepressants for depressive disorders in children and adolescents

Mirtazapine versus other antidepressive agents for depression

Second-generation antipsychotics for major depressive disorder and dysthymia

Disruptive mood dysregulation disorder: current insights

The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of the Development of Guidelines

Prevention of Relapse and Recurrence in Adults with Major Depressive Disorder: Systematic Review and Meta-Analyses of Controlled Trials

The prevalence of comorbid depression in adults with diabetes: a meta-analysis

A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder

Dysrhythmia associated with fluoxetine treatment in an elderly patient with cardiac disease

P304

67-87

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.9758/CPN.2018.16.1.67

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jong-Hyun Jeong

P577

2018-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29397669

http://www.w3.org/2001/XMLSchema#string

P932

5810446

http://www.w3.org/2001/XMLSchema#string